#Clinical Trials

🏢Release 📈 Stocks

Patronus Biotech Secures Approval for Phase I Malaria Vaccine Clinical Trial

October 21, 2026 (3 days ago)

Patronus Biotech advances its malaria vaccine pipeline after receiving regulatory approval for a Phase I human trial in Australia targeting two primary…

Patronus Biotech

🌍 OCEANIA Read More →

📰News 📈 Stocks

EyePoint Pharmaceuticals Shares Slide Following Failed Phase 3 AMD Trial

October 20, 2026 (4 days ago)

EyePoint Pharmaceuticals shares are under pressure as investors weigh a failed Phase 3 trial and controversial data exclusions in the LUGANO study,…

EYPT

🌍 US Read More →

🏢Release 📈 Stocks

PDS Biotechnology Appoints 3 Pharma Veterans to Board to Bolster Pipeline

October 20, 2026 (4 days ago)

PDS Biotechnology adds three industry veterans to its board to accelerate the development of PDS0301 for metastatic colorectal cancer and drive potential…

PDSB

🌍 AMERICAS Read More →

🏢Release 📈 Stocks

Riboscience to Present Phase 1b Data for ENPP1 Inhibitor RBS2418 at ESMO 2026

October 19, 2026 (5 days ago)

Riboscience prepares to showcase Phase 1b clinical data for its lead ENPP1 inhibitor, RBS2418, at the ESMO 2026 medical congress, marking a…

Riboscience

🌍 AMERICAS Read More →

⚡Ad-hoc 📈 Stocks

ALK-Abelló Reports Positive Phase 3 Results for ACARIZAX in China

October 19, 2026 (5 days ago)

ALK-Abelló's ACARIZAX trial in China hits primary efficacy targets, strengthening the company's expansion strategy in partnership with GenSci to address a massive,…

ALKB GenSci

🌍 EUROPE Read More →

🏢Release 📈 Stocks

Actinium Pharmaceuticals to Present Phase 1 Data for ATNM-400 at EANM 2026

October 19, 2026 (5 days ago)

Actinium Pharmaceuticals will showcase Phase 1 clinical results for ATNM-400 at EANM 2026, targeting advancements in prostate and lung cancer treatments beyond…

ATNM

🌍 AMERICAS Read More →

🏢Release 📈 Stocks

IDEAYA Biosciences Shares Rally on Positive Darovasertib Clinical Data

October 19, 2026 (5 days ago)

IDEAYA Biosciences shares gain momentum as new clinical trial data confirms the efficacy of its darovasertib combination therapy in treating metastatic uveal…

IDYA Servier

🌍 GLOBAL Read More →

🏢Release 📈 Stocks

Eli Lilly Omvoh Hits Pediatric Ulcerative Colitis Primary Endpoint

October 19, 2026 (5 days ago)

Eli Lilly eyes label expansion for Omvoh after pediatric ulcerative colitis trial data shows 80% induction response rate, strengthening the drug's clinical…

LLY

🌍 AMERICAS Read More →

🏢Release 📈 Stocks

Mabwell to Present Phase II Data for Nectin-4 ADC 9MW2821 in Breast Cancer

October 19, 2026 (5 days ago)

Mabwell prepares to showcase Phase II clinical data for its 9MW2821 ADC, marking a critical development step for its oncology portfolio in…

688062.SH

🌍 ASIA Read More →

🏢Release 📈 Stocks — 📊 Neutral

Cyrano Therapeutics Presents Clinical Data at 72nd ARS Annual Meeting

October 16, 2026 (8 days ago)

Cyrano Therapeutics earns a spot in the Top 5 Clinical Science track at the 72nd American Rhinologic Society meeting, underscoring the company's…

🌍 AMERICAS Read More →

🏢Release 📈 Stocks

Actinium Pharmaceuticals Shares Rise on Positive ATNM-400 Clinical Data

October 16, 2026 (8 days ago)

Actinium Pharmaceuticals shares gain momentum as new clinical data from EANM 2026 confirms ATNM-400's broad antitumor activity across diverse cancer models, including…

ATNM

🌍 AMERICAS Read More →

🏢Release 📈 Stocks

Alimentiv Partners With IBUS to Launch Ultrasound Training for Clinical Trials

October 15, 2026 (9 days ago)

Alimentiv Inc. expands its clinical trial imaging capabilities through a new partnership with IBUS, launching the IUS-STAR certification program to enhance diagnostic…

Alimentiv Inc.

🌍 GLOBAL Read More →